Genassis

Genassis is redefining pharma go-to-market.

Our mission is clear: leverage AI to accelerate pharma’s go-to-market, making it more efficient, insightful, and impactful. With Genassis, you're not just preparing for the future; you're shaping it.

Genassis is a proprietary AI solution that embodies our commitment to harnessing the power of AI for pharma excellence. With Genassis, we offer deep market insights and advanced data interpretation capabilities. It's not just about data; it's about transforming data into actionable, strategic wisdom that propels you forward.

The inception of Genassis was fuelled by a critical observation of the pharmaceutical data and consultancy sector – a realization of the inherent inefficiencies and excessive costs associated with traditional practices. This understanding sparked a drive to revolutionize by creating a more efficient, value-driven approach.

Genassis is committed to transforming the way pharmaceutical data and consultancy is perceived and delivered in the pharma industry. Our mission is to provide intelligent, data-driven solutions that address the complexities of the pharmaceutical sector. Genassis is at the intersection of traditional industry knowledge and innovative AI technology, offering our clients a pathway to not just meet but exceed their strategic objectives.

Genassis represents a breakthrough in the way Pharma works – it is a tool that harnesses the power of AI to offer predictive analytics, deep market insights, and a new level of strategic foresight.

Genassis is a fine-tuned AI model to accelerate pharma go-to-market and disrupt a $26B consulting and software servies market. Pharma spends $B's to get a drug to-market, and a significant proportion of this goes to consulting services which is costly and time consuming. Genassis changes that by driving unparalleled efficiencies and quicker decision making. It will be available as an enterprise SaaS and as a web application.

Trained on pharma specific data, Genassis allows pharma companies to trust the outputs are correct, Genassis can be adapted for specific needs, and most importantly the company will own the data so proprietary information can be sent to their Genassis to learn and grow with the company over time. It will be seamlessly integrated into a companies workflow e.g. a user sends an email to genassis@company.com asking about market research and the user will get an email back with an answer.

Our vision is to be pharma's largest provider of gen AI co-pilots.